• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌患者来源异种移植模型和原代细胞系的建立。

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines.

作者信息

Lu Jia-Huan, Wang Yun, Meng Qi, Zeng Zhao-Lei

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center;

出版信息

J Vis Exp. 2019 Jul 19(149). doi: 10.3791/59871.

DOI:10.3791/59871
PMID:31380849
Abstract

The use of preclinical models to advance our understanding of tumor biology and investigate the efficacy of therapeutic agents is key to cancer research. Although there are many established gastric cancer cell lines and many conventional transgenic mouse models for preclinical research, the disadvantages of these in vitro and in vivo models limit their applications. Because the characteristics of these models have changed in culture, they no longer model tumor heterogeneity, and their responses have not been able to predict responses in humans. Thus, alternative models that better represent tumor heterogeneity are being developed. Patient-derived xenograft (PDX) models preserve the histologic appearance of cancer cells, retain intratumoral heterogeneity, and better reflect the relevant human components of the tumor microenvironment. However, it usually takes 4-8 months to develop a PDX model, which is longer than the expected survival of many gastric patients. For this reason, establishing primary cancer cell lines may be an effective complementary method for drug response studies. The current protocol describes methods to establish PDX models and primary cancer cell lines from surgical gastric cancer samples. These methods provide a useful tool for drug development and cancer biology research.

摘要

利用临床前模型增进我们对肿瘤生物学的理解并研究治疗药物的疗效是癌症研究的关键。尽管有许多已建立的胃癌细胞系以及许多用于临床前研究的传统转基因小鼠模型,但这些体外和体内模型的缺点限制了它们的应用。由于这些模型的特性在培养过程中发生了变化,它们不再模拟肿瘤异质性,并且它们的反应无法预测人类的反应。因此,正在开发能更好地代表肿瘤异质性的替代模型。患者来源的异种移植(PDX)模型保留了癌细胞的组织学外观,保持了肿瘤内异质性,并能更好地反映肿瘤微环境中的相关人类成分。然而,建立一个PDX模型通常需要4至8个月,这比许多胃癌患者的预期生存期还要长。因此,建立原发性癌细胞系可能是药物反应研究的一种有效补充方法。本方案描述了从手术切除的胃癌样本中建立PDX模型和原发性癌细胞系的方法。这些方法为药物开发和癌症生物学研究提供了一个有用的工具。

相似文献

1
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines.胃癌患者来源异种移植模型和原代细胞系的建立。
J Vis Exp. 2019 Jul 19(149). doi: 10.3791/59871.
2
Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.新型胃癌患者来源异种移植瘤和细胞系的建立:原发肿瘤、患者来源异种移植瘤和细胞系来源异种移植瘤之间的病理比较。
Cells. 2019 Jun 14;8(6):585. doi: 10.3390/cells8060585.
3
[Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].基于患者来源异种移植模型小鼠分子靶向药物细胞内药代动力学分析的药物研发
Yakugaku Zasshi. 2020;140(5):641-648. doi: 10.1248/yakushi.19-00218-5.
4
Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.患者来源的胃癌异种移植模型的建立:一种用于对涉及HER-2、MET和FGFR2信号通路改变的靶向治疗进行临床前评估的有用工具。
BMC Cancer. 2017 Mar 14;17(1):191. doi: 10.1186/s12885-017-3177-9.
5
Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.建立患者来源的异种移植模型并将其作为胃癌临床前模型进行表征。
Sci Rep. 2016 Mar 1;6:22172. doi: 10.1038/srep22172.
6
Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.用于转化性乳腺癌研究的患者来源异种移植模型的最新进展
J Mammary Gland Biol Neoplasia. 2017 Jun;22(2):131-139. doi: 10.1007/s10911-017-9378-7. Epub 2017 Apr 27.
7
Patient-Derived Bladder Cancer Xenografts.患者来源的膀胱癌异种移植模型
Methods Mol Biol. 2018;1655:169-175. doi: 10.1007/978-1-4939-7234-0_14.
8
Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.捕获患者来源异种移植(PDX)模型中的结直肠癌肿瘤间异质性。
Int J Cancer. 2019 Jan 15;144(2):366-371. doi: 10.1002/ijc.31767. Epub 2018 Oct 22.
9
Feasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug Screening.胃癌异种移植(GTX)衍生细胞系用于个体化抗癌药物筛选的可行性。
Anticancer Res. 2022 Jun;42(6):2883-2891. doi: 10.21873/anticanres.15770.
10
Patient-Derived Xenograft Models in Breast Cancer Research.患者来源异种移植模型在乳腺癌研究中的应用。
Adv Exp Med Biol. 2021;1187:283-301. doi: 10.1007/978-981-32-9620-6_14.

引用本文的文献

1
Cholinergic Mechanisms in Gastrointestinal Neoplasia.胆碱能机制在胃肠道肿瘤中的作用。
Int J Mol Sci. 2024 May 13;25(10):5316. doi: 10.3390/ijms25105316.
2
Capsaicin orchestrates metastasis in gastric cancer via modulating expression of TRPV1 channels and driving gut microbiota disorder.辣椒素通过调节 TRPV1 通道的表达和驱动肠道微生物群紊乱来协调胃癌的转移。
Cell Commun Signal. 2023 Dec 21;21(1):364. doi: 10.1186/s12964-023-01265-3.
3
Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
免疫缺陷小鼠中患者来源异种移植模型的生成、演变、干扰因素、应用及挑战
Cancer Cell Int. 2023 Jun 21;23(1):120. doi: 10.1186/s12935-023-02953-3.
4
Patient-Derived Xenograft: A More Standard "Avatar" Model in Preclinical Studies of Gastric Cancer.患者来源的异种移植模型:胃癌临床前研究中更标准化的“化身”模型。
Front Oncol. 2022 May 19;12:898563. doi: 10.3389/fonc.2022.898563. eCollection 2022.
5
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment.从癌症到免疫介导性疾病和诱导耐受:免疫肿瘤学和经典抗癌治疗的经验教训。
Front Immunol. 2020 Jul 8;11:1423. doi: 10.3389/fimmu.2020.01423. eCollection 2020.